This is the first government led testing of quality and outcomes for patients across different conditions. And it delivers on the need for more data collection research into hemp usage. CMS is going to collect data...on the patients that are being given these products by their physicians. In accordance with all the privacy and security regulations, we're going to analyze that data. We're going to make it publicly available to everybody to be able to analyze with us. (10:17–10:23)
CLAIM
Asserts that CMS will collect data on patients using CBD products.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
